AMBER LETHIN: Open Payments
NPI 1053788117 · BREMERTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 16 payments from 6 companies in 2025. Trend: 2023 $65 · 2024 $171 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $205 |
| ABBVIE INC. | 4 | $95 |
| Lundbeck LLC | 2 | $63 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, REXULTI, VRAYLAR, UBRELVY, SHINGRIX, Wegovy, MOUNJARO.
Industry payments across WA — which companies pay providers there.
